ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
3,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
4,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
4,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
6,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,Y
7,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
7,2,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
7,3,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
7,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
8,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
10,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
11,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
12,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
13,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
14,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
15,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
16,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
18,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
18,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
18,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
18,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
18,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,9,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,10,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
18,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
19,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
20,2,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
21,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
21,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
22,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
23,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
24,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
25,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
25,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
25,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
25,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
27,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
27,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
27,3,C-reactive protein decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
27,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
27,5,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
27,6,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
27,7,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
27,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
27,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
27,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
27,11,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
27,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
28,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
29,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
30,1,Acute on chronic liver failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
30,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
31,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
31,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
32,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
33,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
33,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
34,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
34,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
35,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
35,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
36,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
37,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
38,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
38,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
39,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
39,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
39,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
39,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
39,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
40,1,Alpha 1 foetoprotein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
41,1,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
42,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
42,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
43,1,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
43,2,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
44,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
44,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
44,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
44,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
45,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
45,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
46,1,Laboratory test interference,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
47,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
47,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
48,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
48,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
48,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
48,5,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,Y
48,6,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
48,7,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
48,8,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
48,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
48,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
48,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
49,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
52,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
53,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
54,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
54,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
54,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
57,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
58,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
59,1,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
60,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
61,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
62,1,Pyoderma,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
63,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
63,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
64,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
64,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
65,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
65,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,3,Spontaneous bacterial peritonitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
65,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
67,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
68,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
69,1,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
70,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
71,1,Mononeuropathy,Mononeuropathies,Peripheral neuropathies,Nerv,N
72,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
73,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
73,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
73,3,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
73,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
74,1,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
75,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
76,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
77,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
77,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
78,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
78,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
79,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
80,1,Gilbert's syndrome,Inborn errors of bilirubin metabolism,Metabolic and nutritional disorders congenital,Cong,N
80,2,Jaundice acholuric,Haemolyses NEC,Haemolyses and related conditions,Blood,N
81,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
81,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
83,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
83,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
83,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
84,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
84,2,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
84,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
85,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
85,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
86,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
86,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
88,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
89,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
90,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
92,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
93,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
94,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
94,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
95,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
96,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
96,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
96,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
97,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
97,2,Ear disorder,Ear disorders NEC,Aural disorders NEC,Ear,N
97,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
97,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
97,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
98,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
98,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
98,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
98,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
98,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
99,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
99,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
100,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
101,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
101,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
101,3,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
101,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
102,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
102,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
103,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
105,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
105,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
105,3,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
106,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
106,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
107,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
108,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
108,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
108,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
108,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
108,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
108,6,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
109,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
109,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
111,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
112,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
112,2,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
112,3,Metastases to peritoneum,Metastases to specified sites,Metastases,Neopl,N
112,4,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
113,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
114,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
114,2,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
114,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
114,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
114,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
115,1,Cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
116,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
116,3,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
117,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
117,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
118,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
118,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
118,3,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
119,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
119,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
120,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
121,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
121,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
122,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
123,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
123,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
123,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
123,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
123,5,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
124,1,Chronic pigmented purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
124,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
124,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
125,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
126,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
127,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
127,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
127,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
127,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
127,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
128,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
129,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
130,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
130,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
130,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
130,4,Lymphangitis,Vascular infections,Infections - pathogen unspecified,Infec,N
130,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
131,1,Bleeding varicose vein,Varicose veins NEC,Venous varices,Vasc,N
131,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
132,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
133,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
134,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
134,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
135,1,Motion sickness,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
135,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
136,1,Blepharitis,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
137,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
137,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
138,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
138,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
139,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
140,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
141,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
142,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
142,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
143,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
144,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
144,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
145,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
146,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
147,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
148,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
149,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
149,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
150,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
150,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
151,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
151,2,Migraine without aura,Migraine headaches,Headaches,Nerv,N
151,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
152,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
152,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
153,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
153,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
154,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
154,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
154,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
156,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
156,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
156,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
156,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
157,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
157,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
157,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
157,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
157,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
158,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
159,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
160,1,Arthropod bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
160,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
160,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
160,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
161,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
161,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
162,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
162,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
162,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
163,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
164,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
164,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
164,3,Headache,Headaches NEC,Headaches,Nerv,N
164,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
164,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
165,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
165,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
166,1,Primary hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
167,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
167,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
167,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
168,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
169,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
169,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
170,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,2,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
170,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
172,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
172,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
173,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
174,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
175,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
175,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
176,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
177,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
177,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
178,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
178,2,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
179,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
180,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
180,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
181,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
182,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
182,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
183,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
183,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
184,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
184,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
185,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
185,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
186,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
187,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
188,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
189,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
190,1,Anal squamous cell carcinoma,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
190,2,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
190,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
190,4,Bone marrow infiltration,Haematological disorders,Haematological disorders NEC,Blood,N
190,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
190,6,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
190,7,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
190,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
191,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
191,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
192,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
192,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
192,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
193,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
194,1,Tendon pain,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
195,1,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
196,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
197,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
198,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
199,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
199,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
199,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
199,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
200,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,Y
201,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
201,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
201,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
201,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
201,5,Headache,Headaches NEC,Headaches,Nerv,N
201,6,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
201,7,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
201,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
202,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
202,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,Y
203,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
203,2,Drug level changed,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
203,3,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
204,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
204,2,Drug level changed,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
204,3,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
205,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
205,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
206,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
207,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
208,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
209,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
209,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
210,1,Headache,Headaches NEC,Headaches,Nerv,N
210,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
211,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
211,2,Impatience,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
211,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
211,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
212,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
212,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
213,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
214,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
215,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
215,2,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
215,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
216,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
216,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
216,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
216,4,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,Y
216,5,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
217,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
218,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
219,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
219,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
219,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
219,5,Impatience,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
220,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
220,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
220,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
221,1,Alcoholism,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
221,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
221,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
222,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
222,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
223,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
223,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
223,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
223,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
223,5,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
223,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
224,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
224,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
225,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
225,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
226,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
226,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
226,3,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
227,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
228,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
228,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
229,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
230,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
230,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
231,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
232,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
232,2,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
233,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
234,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
235,1,Disease complication,General signs and symptoms NEC,General system disorders NEC,Genrl,N
235,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
235,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
236,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
236,2,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
236,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
237,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
237,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
238,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
238,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
239,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
239,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
239,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
240,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
240,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
241,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
241,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
242,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
243,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
244,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
245,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
246,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
246,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
247,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
247,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
247,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
247,4,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
248,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
248,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
248,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
249,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
249,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
249,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
250,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
250,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
251,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
251,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
252,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
253,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
253,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
253,3,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
253,4,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
253,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
253,6,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
254,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
254,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
255,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
256,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
256,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
256,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
256,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
257,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,1,Corrected transposition of great vessels,Great vessel disorders congenital,Cardiac and vascular disorders congenital,Cong,N
259,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
260,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
260,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
260,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
260,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
261,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
261,2,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
261,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
261,4,Prostatic pain,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
261,5,Prostatitis,Prostate and seminal vesicles infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
261,6,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
261,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
262,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
263,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,Y
264,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
264,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
264,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
264,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
265,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
265,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
265,3,Tension headache,Headaches NEC,Headaches,Nerv,N
266,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
266,2,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
266,3,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
267,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
267,2,Headache,Headaches NEC,Headaches,Nerv,N
268,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
269,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
269,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
270,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
270,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
270,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
271,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
271,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
271,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
272,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
273,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
273,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
273,3,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
273,4,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
273,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
273,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
274,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
274,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
275,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
276,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
276,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
277,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
278,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
278,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
279,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
279,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
280,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
281,1,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
282,1,Headache,Headaches NEC,Headaches,Nerv,N
283,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
283,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
284,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
285,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
286,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
287,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
287,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
288,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
288,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
289,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
289,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
289,3,"Delusional disorder, unspecified type",Delusional disorders,Schizophrenia and other psychotic disorders,Psych,N
289,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
289,5,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
289,6,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
290,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
290,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
290,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
290,4,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
290,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
291,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
292,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
293,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
294,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
294,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
295,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
295,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
296,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
296,2,Headache,Headaches NEC,Headaches,Nerv,N
296,3,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
297,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
297,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
298,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
299,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
300,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
301,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
301,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
301,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
302,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
302,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
303,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
304,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
305,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
305,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
305,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
306,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
306,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
308,2,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
308,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
309,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
309,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
310,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
311,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
312,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
312,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
312,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
313,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
313,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
313,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
313,4,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
313,5,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
314,1,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
314,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
314,3,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
314,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
316,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
317,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
317,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
318,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
318,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
319,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
319,2,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
319,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
319,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
319,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
319,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
319,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
319,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
320,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
320,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
321,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
321,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
321,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
322,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
322,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
322,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
322,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
322,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
322,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
323,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
324,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
324,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
324,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
324,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
325,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
326,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
327,1,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
328,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
328,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
329,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
329,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
330,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
330,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
330,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
330,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
331,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
332,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
333,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
333,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
333,3,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
333,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
334,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
334,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
334,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
334,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
334,5,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
335,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
336,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
336,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
337,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
337,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
338,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,3,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
338,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
338,5,Headache,Headaches NEC,Headaches,Nerv,N
338,6,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
339,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
339,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
340,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
341,1,Headache,Headaches NEC,Headaches,Nerv,N
341,2,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
341,3,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
341,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
341,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
342,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
343,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
344,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
344,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
345,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
346,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
346,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
346,3,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
347,1,Lung cancer metastatic,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
348,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
349,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
350,1,Gallbladder cancer,Gallbladder neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
351,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
351,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
351,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
352,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
352,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
353,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
354,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
354,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
354,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
354,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
354,5,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
355,1,Hepatitis D RNA positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
356,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
357,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
358,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
358,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
359,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
359,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
360,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
360,2,Headache,Headaches NEC,Headaches,Nerv,N
360,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
360,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
361,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
362,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
362,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
362,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
363,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
363,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
364,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
365,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
365,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
365,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
365,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
366,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
367,1,Adjustment disorder with mixed anxiety and depressed mood,Adjustment disorders,Adjustment disorders (incl subtypes),Psych,N
368,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
368,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
369,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
370,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
370,2,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
371,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
372,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
372,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
372,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
373,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
373,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
373,3,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
373,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
373,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
373,6,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
374,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
375,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
375,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
375,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
376,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
377,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
377,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
377,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
378,1,Tension headache,Headaches NEC,Headaches,Nerv,N
379,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
380,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
380,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
381,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
381,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
382,1,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
383,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
384,1,Oesophageal varices haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
385,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
385,2,Headache,Headaches NEC,Headaches,Nerv,N
385,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
385,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
386,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
387,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
388,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
389,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
389,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
389,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
390,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
391,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
391,2,Migraine,Migraine headaches,Headaches,Nerv,N
391,3,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
392,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
392,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
392,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
392,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
392,5,Deafness,Hearing losses,Hearing disorders,Ear,N
392,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
392,7,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
392,8,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
392,9,Dissociation,Dissociative states,Dissociative disorders,Psych,N
392,10,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
392,11,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
392,12,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
392,13,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
392,14,Headache,Headaches NEC,Headaches,Nerv,N
392,15,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
392,16,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
392,17,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
392,18,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
392,19,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
392,20,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
392,21,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
392,22,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
392,23,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
393,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
393,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
393,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
394,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
394,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
395,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
395,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
395,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
395,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
396,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
396,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
396,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
397,1,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
397,2,Endotracheal intubation,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
397,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
397,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
398,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
399,1,Nipple pain,Breast signs and symptoms,Breast disorders,Repro,N
400,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
400,2,Tongue exfoliation,Tongue signs and symptoms,Tongue conditions,Gastr,N
401,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
401,2,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
402,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
402,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
403,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
403,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
404,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
405,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
406,1,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
406,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
407,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
408,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
409,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
410,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
411,1,T-cell chronic lymphocytic leukaemia,Leukaemias chronic T-cell,Leukaemias,Neopl,N
412,1,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
412,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
412,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
413,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
414,1,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
414,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
414,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
415,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
415,2,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
415,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
416,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
416,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
417,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
417,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
418,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
419,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
419,2,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
420,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
420,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
421,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
422,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
422,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
422,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
423,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
424,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
425,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
426,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
426,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
426,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
426,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
427,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
428,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
428,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
429,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
430,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
430,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
431,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
432,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
432,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
433,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
433,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
433,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
433,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
434,1,Headache,Headaches NEC,Headaches,Nerv,N
434,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
435,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
435,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
436,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
436,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
437,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
438,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
438,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
438,3,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
438,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
439,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
440,1,Essential hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
440,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
441,1,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
442,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
442,2,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
442,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
443,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
444,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
445,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
446,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
446,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
447,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
447,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
447,3,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
448,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
449,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
450,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
450,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
451,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
451,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
452,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
453,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
454,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
455,1,Hodgkin's disease stage IV,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
456,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
457,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
457,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
457,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
458,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
459,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
459,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
460,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
461,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
461,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
462,1,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
463,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
463,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
464,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
464,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
465,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
465,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
465,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
465,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
466,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
466,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
466,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
467,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
468,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
468,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
469,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
470,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
470,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
471,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
471,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
471,3,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
472,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
473,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
474,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
474,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
474,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
474,4,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
475,1,Headache,Headaches NEC,Headaches,Nerv,N
475,2,Infrequent bowel movements,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
475,3,Irregular sleep wake rhythm disorder,Disturbances in sleep phase rhythm,Sleep disturbances (incl subtypes),Nerv,N
476,1,Chronic hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
476,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
477,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
477,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
478,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
478,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
479,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
479,2,Headache,Headaches NEC,Headaches,Nerv,N
479,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
479,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
480,1,Alpha 1 foetoprotein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
480,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
480,3,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
481,1,Migraine,Migraine headaches,Headaches,Nerv,N
482,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
482,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
482,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
482,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
483,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
484,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
484,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
484,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
485,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
485,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
485,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
486,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
487,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
487,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
488,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
488,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
489,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
489,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
490,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
490,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
490,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
491,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
491,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
492,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
492,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
492,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
493,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
493,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
493,3,Headache,Headaches NEC,Headaches,Nerv,N
493,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
493,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
493,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
494,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
494,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
494,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
495,1,Anal squamous cell carcinoma,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
496,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
497,1,Headache,Headaches NEC,Headaches,Nerv,N
497,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
498,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
499,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
499,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
499,3,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
499,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
499,5,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
499,6,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
499,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
500,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
501,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
501,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
501,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
501,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
501,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
502,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
502,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
503,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
503,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
503,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
503,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
503,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
503,6,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
503,7,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
504,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
504,2,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
504,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
504,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
505,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
506,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
507,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
508,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
508,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
509,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
509,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
509,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
510,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
511,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
512,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
513,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
513,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
514,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
514,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
514,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
514,4,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
514,5,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
514,6,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
514,7,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
515,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
515,2,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
515,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
515,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
515,5,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
515,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
515,7,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
515,8,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
515,9,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
516,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
516,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
517,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
518,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
518,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
519,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
519,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
520,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
520,2,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
521,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
521,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
521,3,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
521,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
522,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
522,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
523,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
523,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
524,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
525,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
526,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
526,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
527,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
527,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
527,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
527,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
528,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
529,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
530,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
531,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
531,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
531,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
532,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
533,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
533,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
534,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
534,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
535,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
535,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
536,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
537,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
537,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
538,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
539,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
539,2,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
539,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
540,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
540,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
541,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
542,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
543,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
543,2,Photoelectric conjunctivitis,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
543,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
544,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
545,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
546,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
546,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
546,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
546,4,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
546,5,Physical assault,Criminal activity,Legal issues,SocCi,N
547,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
547,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
548,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
549,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
550,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
550,2,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
551,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
552,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
553,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
554,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
554,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
555,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
556,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
557,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
558,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
558,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
558,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
558,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
559,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
559,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
559,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
559,4,Intrusive thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
559,5,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
559,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
559,7,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
559,8,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
560,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
561,1,Headache,Headaches NEC,Headaches,Nerv,N
562,1,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
563,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
563,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
563,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
564,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
564,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
565,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
565,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
566,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,3,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
566,4,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
566,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
567,1,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
567,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
568,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
568,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
569,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
570,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
571,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
572,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
573,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
574,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
575,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
575,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
576,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
577,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
578,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
578,2,Headache,Headaches NEC,Headaches,Nerv,N
578,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
578,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
579,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
579,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
580,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
581,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
582,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
582,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
583,1,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
583,2,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
584,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
584,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
585,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
585,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
586,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
586,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
587,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
587,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
588,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
589,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
590,1,Acute on chronic liver failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
590,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
590,3,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
590,4,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
591,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
591,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
592,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
592,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
592,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
593,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
593,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
594,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
594,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
594,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
594,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
594,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
594,6,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,Y
594,7,Hepatitis C RNA,Virus identification and serology,Microbiology and serology investigations,Inv,N
594,8,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
594,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
595,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
595,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
595,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
596,1,Blood iron increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
597,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
598,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
599,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
600,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
600,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
601,1,Genotype drug resistance test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
601,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
602,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
602,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
602,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
603,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
603,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
603,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
604,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
605,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
606,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
607,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
608,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
608,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
609,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
609,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
610,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
610,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
611,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
611,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
611,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
612,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
612,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
613,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
613,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
613,3,Electric shock sensation,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
613,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
614,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
615,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
616,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
617,1,Hepatitis C RNA positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
617,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
617,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
618,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
619,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
620,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
620,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
